Oncopeptides AB (publ) (LON: 0RN4)
London flag London · Delayed Price · Currency is GBP · Price in SEK
1.344
-0.018 (-1.32%)
At close: Jan 21, 2025

Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 21.22 million as of January 23, 2025. Its market cap has decreased by -62.04% in one year.

Market Cap
21.22M
Enterprise Value
11.43M
Revenue
1.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.34

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 21.22M, a decrease of -85.76%. That is a compound annual growth rate of -21.82%.

History

DateMarket Cap% Change
Jan 22, 202521.22M-12.40%
Dec 30, 202424.23M-57.05%
Dec 29, 202356.41M-38.17%
Dec 30, 202291.23M76.11%
Dec 30, 202151.80M-94.99%
Dec 30, 20201.03B80.19%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 171.37B
Shell 167.06B
HSBC Holdings 144.71B
Unilever 113.14B
Rio Tinto Group 85.64B
RELX PLC 74.07B
BP p.l.c. 67.25B
British American Tobacco p.l.c. 65.03B
Market Cap Rankings